glp-1 for hs The Therapeutic Potential of Receptor Agonists in the Management of Hidradenitis Suppurativa: A Systematic Review of Anti-Inflammatory and Metabolic Effects GLP-1-based therapies for type 2

Obuseng et al., 2012

I think there is considerable potential for this drug (and class) as a treatment for obstructive sleep apnea

You'll draw more units for the same dose

The incidence of PCD is about 1 : 40000 with an approximate carrier rate of 1%, although this frequency has been reported to be higher in the Faroe Islands, an isolated archipelago in the North Atlantic.9-11) The disease is caused by heterogeneous mutations of SLC22A5 which encodes the high-affinity carnitine transporter OCTN2 in the plasma membrane.12), 13) OCTN2 is strongly expressed in the myocardium, skeletal muscle, renal tubules, fibroblasts, intestine and placental tissue.14), 15) The Na + -coupled active transport of carnitine via OCTN2 is essential for the maintenance of high carnitine concentrations inside cells

AI-translated Product Info AI-translated Product Info Global Reviews ( review }) No reviews submitted yet